Variation in post‐TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry

[1]  J. Webb,et al.  Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial. , 2017, JACC. Cardiovascular interventions.

[2]  P. Stella,et al.  Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation. , 2016, American heart journal.

[3]  M. Farkouh,et al.  Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis. , 2015, The Canadian journal of cardiology.

[4]  John D. Carroll,et al.  Clinical outcomes at 1 year following transcatheter aortic valve replacement. , 2015, JAMA.

[5]  R. Pathak,et al.  Dual versus single antiplatelet therapy in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. , 2015, Heart, lung & circulation.

[6]  Nancy M Albert,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, The Journal of thoracic and cardiovascular surgery.

[7]  B. Trimarco,et al.  SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. , 2014, International journal of cardiology.

[8]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[9]  J. Mega,et al.  Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. , 2013, Journal of the American College of Cardiology.

[10]  Danica Marinac-Dabic,et al.  The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. , 2013, Journal of the American College of Cardiology.

[11]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[12]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[13]  Sean M. O'Brien,et al.  Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. , 2012, Journal of the American College of Cardiology.

[14]  D. Capodanno,et al.  Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. , 2011, The American journal of cardiology.

[15]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[16]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.